Skip to main content
Michael Leapman, MD, Urology, New Haven, CT

Michael Stuart Leapman MD

Surgical Oncology


Physician

Join to View Full Profile
  • 800 Howard AvenueYale Physicians BuildingNew Haven, CT 06519

Dr. Leapman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2014 - 2016
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Urology, 2010 - 2014
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 2009 - 2010
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2009

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • Urology
    American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer  
    Michael Leapman, MD, JAMA Oncology

Lectures

  • Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • How to Avoid Overtreatment of Prostate Cancer
    How to Avoid Overtreatment of Prostate CancerJanuary 15th, 2025
  • PSMA-PET Detects Hidden Metastasis in Recurrent Prostate Cancer
    PSMA-PET Detects Hidden Metastasis in Recurrent Prostate CancerJanuary 8th, 2025
  • More Patients Opting for Close Monitoring of Early Stage Prostate Cancer
    More Patients Opting for Close Monitoring of Early Stage Prostate CancerNovember 22nd, 2024
  • Join now to see all

Grant Support

  • Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imagingYALE UNIVERSITY2023–2028

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: